Peer-reviewed articles

EUROCARE-5 Working Group, Bielska-Lasota M, Rossi S, et al. Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study. Arch Gynecol Obstet. 2020;301(2):591-602. doi:10.1007/s00404-019-05412-5

O’Connor M, O’Donovan B, Waller J, et al. Communicating about HPV in the context of head and neck cancer: A systematic review of quantitative studies. Patient Educ Couns. 2020;103(3):462-472. doi:10.1016/j.pec.2019.09.017

Schliemann D, Paramasivam D, Dahlui M, et al. Change in public awareness of colorectal cancer symptoms following the Be Cancer Alert Campaign in the multi-ethnic population of Malaysia. BMC Cancer. 2020;20(1):252. doi:10.1186/s12885-020-06742-3

Cabasag CJ, Butler J, Arnold M, et al. Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): A population-based study. Gynecol Oncol. 2020;157(1):234-244. doi:10.1016/j.ygyno.2019.12.047

Molina-Montes E, Van Hoogstraten L, Gomez-Rubio P, et al. Pancreatic Cancer Risk in Relation to Lifetime Smoking Patterns, Tobacco Type, and Dose-Response Relationships. Cancer Epidemiol Biomarkers Prev. 2020;29(5):1009-1018. doi:10.1158/1055-9965.EPI-19-1027

O’Connor M, Waller J, Gallagher P, et al. Barriers and facilitators to discussing HPV with head and neck cancer patients: A qualitative study using the theoretical domains framework. Patient Educ Couns. Published online May 30, 2020:S0738-3991(20)30318-9. doi:10.1016/j.pec.2020.05.032

Virgili G, Parravano M, Gatta G, et al. Incidence and Survival of Patients With Conjunctival Melanoma in Europe. JAMA Ophthalmol. 2020;138(6):601. doi:10.1001/jamaophthalmol.2020.0531

O’Connor M, O’Donovan B, Waller J, et al. The role of healthcare professionals in HPV communication with head and neck cancer patients: A narrative synthesis of qualitative studies. Eur J Cancer Care (Engl). 2020;29(4):e13241. doi:10.1111/ecc.13241

Botta L, Gatta G, Trama A, et al. Incidence and survival of rare cancers in the US and Europe. Cancer Medicine. 2020;9(15):5632-5642. doi:10.1002/cam4.3137

Locati L, Cavalieri S, Dal Maso L, et al. Rare thyroid malignancies in Europe: Data from the information network on rare cancers in Europe (RARECAREnet). Oral Oncology. 2020;108:104766. doi:10.1016/j.oraloncology.2020.104766

Martin P, O’Leary E, Deady S, Horgan A. The Uptake and Efficacy of Neoadjuvant Therapy in Older Adults with Locally Advanced Esophogastric Cancer. J Gastrointest Cancer. 2020;51(3):893-900. doi:10.1007/s12029-019-00320-y

Murray SL, O’Leary E, De Bhailís ÁM, et al. Cancer survival in kidney transplant recipients in Ireland. Nephrol Dial Transplant. 2020;35(10):1802-1810. doi:10.1093/ndt/gfaa109

Alken S, Owens C, Gilham C, et al. Survival of childhood and adolescent/young adult (AYA) cancer patients in Ireland during 1994-2013: comparisons by age. Ir J Med Sci. 2020;189(4):1223-1236. doi:10.1007/s11845-020-02236-0

Murray SL, Daly FE, O’Kelly P, et al. The impact of switching to mTOR inhibitor-based immunosuppression on long-term non-melanoma skin cancer incidence and renal function in kidney and liver transplant recipients. Ren Fail. 2020;42(1):607-612. doi:10.1080/0886022X.2020.1785499

Kelly M, O’Brien KM, Hannigan A. Using administrative health data for palliative and end of life care research in Ireland: potential and challenges. HRB Open Res. 2021;4:17. doi:10.12688/hrbopenres.13215.2

O’Connor M, McSherry LA, Dombrowski SU, et al. Identifying ways to maximise cervical screening uptake: a qualitative study of GPs’ and practice nurses’ cervical cancer screening-related behaviours. HRB Open Res. 2021;4:44. doi:10.12688/hrbopenres.13246.1

Araghi M, Arnold M, Rutherford MJ, et al. Colon and rectal cancer survival in seven high-income countries 2010-2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project). Gut. 2021;70(1):114-126. doi:10.1136/gutjnl-2020-320625

Molina-Montes E, Coscia C, Gómez-Rubio P, et al. Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses. Gut. 2021;70(2):319-329. doi:10.1136/gutjnl-2019-319990

Morgan E, Soerjomataram I, Gavin AT, et al. International trends in oesophageal cancer survival by histological subtype between 1995 and 2014. Gut. 2021;70(2):234-242. doi:10.1136/gutjnl-2020-321089

López de Maturana E, Rodríguez JA, Alonso L, et al. A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer. Genome Med. 2021;13(1):15. doi:10.1186/s13073-020-00816-4

Andersson TML, Myklebust TÅ, Rutherford MJ, et al. The impact of excluding or including Death Certificate Initiated (DCI) cases on estimated cancer survival: A simulation study. Cancer Epidemiol. 2021;71(Pt A):101881. doi:10.1016/j.canep.2020.101881

Pilleron S, Charvat H, Araghi M, et al. Age disparities in stage-specific colon cancer survival across seven countries: An International Cancer Benchmarking Partnership SURVMARK-2 population-based study. Int J Cancer. 2021;148(7):1575-1585. doi:10.1002/ijc.33326

Cardoso R, Guo F, Heisser T, et al. Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study. Lancet Oncol. 2021;22(7):1002-1013. doi:10.1016/S1470-2045(21)00199-6

Prior L, O’Dwyer R, Farooq AR, et al. Pregnancy-associated breast cancer: evaluating maternal and foetal outcomes. A national study. Breast Cancer Res Treat. 2021;189(1):269-283. doi:10.1007/s10549-021-06263-y

O’Connor M, Céilleachair AÓ, O’Brien K, et al. Health-related quality of life in women after colposcopy: results from a longitudinal patient survey. Qual Life Res. 2021;30(9):2509-2520. doi:10.1007/s11136-021-02831-3